The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers-Reference-Cited by-同舟云学术

The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers

Published:2016-07-28 Issue:13 Volume:43 Page:2360-2373
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Apostolova Ivayla,Ego Kilian,Steffen Ingo G.,Buchert Ralph,Wertzel Heinz,Achenbach H. Jost,Riedel Sandra,Schreiber Jens,Schultz Meinald,Furth Christian,Derlin Thorsten,Amthauer Holger,Hofheinz Frank,Kalinski Thomas

Funder

none

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-016-3452-z.pdf

Reference40 articles.

1. Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, et al. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003;348:2500–7.

2. Berghmans T, Paesmans M, Sculier JP. Prognostic factors in stage III non-small cell lung cancer: a review of conventional, metabolic and new biological variables. Ther Adv Med Oncol. 2011;3:127–38. doi: 10.1177/1758834011401951 .

3. Roy S, Pathy S, Kumar R, Mohanti BK, Raina V, Jaiswal A, et al. Efficacy of 18F-fluorodeoxyglucose positron emission tomography/computed tomography as a predictor of response in locally advanced non-small-cell carcinoma of the lung. Nucl Med Commun. 2016;37:129–38. doi: 10.1097/MNM.0000000000000422 .

4. Cook GJ, Yip C, Siddique M, Goh V, Chicklore S, Roy A, et al. Are pretreatment 18F-FDG PET tumor textural features in non-small cell lung cancer associated with response and survival after chemoradiotherapy? J Nucl Med. 2013;54:19–26. doi: 10.2967/jnumed.112.107375 .

5. Eary JF, O’Sullivan F, O’Sullivan J, Conrad EU. Spatial heterogeneity in sarcoma 18F-FDG uptake as a predictor of patient outcome. J Nucl Med. 2008;49:1973–9. doi: 10.2967/jnumed.108.053397 .

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising Candidate Prognostic Biomarkers in [¹⁸F]FDG PET Images: Evaluation in Independent Cohorts of Non–Small Cell Lung Cancer Patients;Journal of Nuclear Medicine;2024-03-07

2. Bronchogenic carcinoma: the added value of FDG PET/CT advanced volumetric and metabolic parameters in initial evaluation and their impact on prognosis and clinical outcome;Egyptian Journal of Radiology and Nuclear Medicine;2024-02-19

3. An assessment of PET and CMR radiomic features for the detection of cardiac sarcoidosis;Frontiers in Nuclear Medicine;2024-01-16

4. The HIF-1α/PKM2 Feedback Loop in Relation to EGFR Mutational Status in Lung Adenocarcinoma;Journal of Investigative Surgery;2024-01-15

5. Combination of tumor asphericity and an extracellular matrix-related prognostic gene signature in non-small cell lung cancer patients;Scientific Reports;2023-11-27